Matthew Ackers-Johnson Selected Research

Matthew Ackers-Johnson Research Topics

2	Inflammation (Inflammations) 01/2018 - 04/2015
2	Vascular Diseases (Vascular Disease) 04/2015 - 10/2013
1	Cardiotoxicity 01/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Cardiomegaly (Heart Hypertrophy) 01/2020
1	familial dilated cardiomyopathy 10/2019
1	Heart Diseases (Heart Disease) 10/2018
1	Mucopolysaccharidosis VI (Syndrome, Maroteaux-Lamy) 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Hypoxia (Hypoxemia) 09/2016
1	Atherosclerosis 04/2015
1	Neointima 10/2013
1	Vascular System Injuries 10/2013
1	Type 2 Diabetes Mellitus (MODY) 03/2011

2	myocardinIBA 04/2015 - 10/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	AnthracyclinesIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Circular RNAIBA 01/2020
1	LaminsIBA 10/2019
1	RNA (Ribonucleic Acid)IBA 10/2018
1	N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B)IBA 01/2018
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2018
1	GlycosaminoglycansIBA 01/2018
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 01/2018
1	CalciumIBA 09/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2016
1	ApolipoproteinsIBA 04/2015
1	Transcription Factors (Transcription Factor)IBA 03/2011

1	Enzyme Replacement Therapy 01/2018